glp-1 video Understanding Medications My Journey with GLP-1: A
Description
J Clin Endocrinol Metab (2013) 98(4):E66471
Hold this thought in your mind while I jump to a similar but different topic
However, these observations are subject to significant methodological constraints
doi: 10.1056/NEJMoa1707914
Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity
So, the hair changes observed during Wegovy therapy are likely not a result of the drug itself, but rather the physiological effects of weight loss
